Tower Research Capital LLC (Trc) Anixa Biosciences Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,483 shares of ANIX stock, worth $4,656. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,483
Previous 6,379
76.75%
Holding current value
$4,656
Previous $14,000
71.43%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ANIX
# of Institutions
60Shares Held
5.56MCall Options Held
21KPut Options Held
6.7K-
Vanguard Group Inc Valley Forge, PA1.39MShares$4.37 Million0.0% of portfolio
-
D.A. Davidson & Co.671KShares$2.11 Million0.02% of portfolio
-
Laird Norton Trust Company, LLC621KShares$1.95 Million0.26% of portfolio
-
Ubs Group Ag529KShares$1.66 Million0.0% of portfolio
-
Mission Wealth Management, LP510KShares$1.6 Million0.04% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $96.3M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...